α-Synuclein promotes IAPP fibril formation in vitro and β-cell amyloid formation in vivo in mice
Abstract Type 2 diabetes (T2D), alike Parkinson’s disease (PD), belongs to the group of protein misfolding diseases (PMDs), which share aggregation of misfolded proteins as a hallmark. Although the major aggregating peptide in β-cells of T2D patients is Islet Amyloid Polypeptide (IAPP), alpha-synucl...
Main Authors: | Marija Mucibabic, Pär Steneberg, Emmelie Lidh, Jurate Straseviciene, Agnieszka Ziolkowska, Ulf Dahl, Emma Lindahl, Helena Edlund |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-77409-z |
Similar Items
-
Mechanisms of Transthyretin Inhibition of IAPP AmyloidFormation
by: Sanduni Wasana Jayaweera, et al.
Published: (2021-03-01) -
Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin
by: Boisbouvier, J., et al.
Published: (2022) -
Macromolecular crowding as a suppressor of human IAPP fibril formation and cytotoxicity.
by: Janine Seeliger, et al.
Published: (2013-01-01) -
Effects of Protein Corona on IAPP Amyloid Aggregation, Fibril Remodelling, and Cytotoxicity
by: Emily H. Pilkington, et al.
Published: (2017-05-01) -
General amyloid inhibitors? A critical examination of the inhibition of IAPP amyloid formation by inositol stereoisomers.
by: Hui Wang, et al.
Published: (2014-01-01)